<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8461710</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">34180414</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8461710</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">JAD210159</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3233/JAD-210159</article-id></all-ids><extracted-table><table-id>jad-82-jad210159-t001</table-id><table-label>Table 1</table-label><table-caption>Sociodemographic Characteristics of Study Completers</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="jad-82-jad210159-t001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Sociodemographic Characteristics of Study Completers</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Screened for eligibility<sup>1</sup></td><td rowspan="1" colspan="1">Completed Screening</td><td rowspan="1" colspan="1">Enrolled in Study</td><td rowspan="1" colspan="1">Completed Study</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">320</td><td rowspan="1" colspan="1">139</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">Sex, no. (%)</td></tr><tr><td rowspan="1" colspan="1">  Male</td><td rowspan="1" colspan="1">232 (73%)</td><td rowspan="1" colspan="1">85 (61%)</td><td rowspan="1" colspan="1">26 (63%)</td><td rowspan="1" colspan="1">11 (61%)</td></tr><tr><td rowspan="1" colspan="1">  Female</td><td rowspan="1" colspan="1">88 (28%)</td><td rowspan="1" colspan="1">54 (39%)</td><td rowspan="1" colspan="1">15 (37%)</td><td rowspan="1" colspan="1">7 (39%)</td></tr><tr><td rowspan="1" colspan="1">MCI diagnosis, no. (%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">40 (29%)</td><td rowspan="1" colspan="1">10 (24%)</td><td rowspan="1" colspan="1">5 (28%)</td></tr><tr><td rowspan="1" colspan="1">SMD, no. (%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">87 (63%)</td><td rowspan="1" colspan="1">31 (76%)</td><td rowspan="1" colspan="1">13 (72%)</td></tr><tr><td rowspan="1" colspan="1">Age, mean (SD)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">72.0 (11.0)</td><td rowspan="1" colspan="1">73.1 (9.8)</td><td rowspan="1" colspan="1">75.6 (9.1)</td></tr><tr><td rowspan="1" colspan="1">Education, mean (SD), y</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">15.7 (2.8)</td><td rowspan="1" colspan="1">15.5 (2.1)</td><td rowspan="1" colspan="1">14.8 (2.5)</td></tr><tr><td rowspan="1" colspan="1">Race, no. (%)</td></tr><tr><td rowspan="1" colspan="1">  Caucasian</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">99 (71%)</td><td rowspan="1" colspan="1">31 (76%)</td><td rowspan="1" colspan="1">16 (89%)</td></tr><tr><td rowspan="1" colspan="1">  Asian/Pacific Islander</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">10 (7%)</td><td rowspan="1" colspan="1">4 (10%)</td><td rowspan="1" colspan="1">2 (11%)</td></tr><tr><td rowspan="1" colspan="1">  Hispanic or Latino</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">14 (10%)</td><td rowspan="1" colspan="1">1 (2%)</td><td rowspan="1" colspan="1">1 (6%)</td></tr><tr><td rowspan="1" colspan="1">  African American</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">18 (13%)</td><td rowspan="1" colspan="1">5 (12%)</td><td rowspan="1" colspan="1">0 (0%)</td></tr><tr><td rowspan="1" colspan="1">  Other</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">16 (12%)</td><td rowspan="1" colspan="1">4 (10%)</td><td rowspan="1" colspan="1">2 (11%)</td></tr><tr><td rowspan="1" colspan="1">Marital status, no. (%)</td></tr><tr><td rowspan="1" colspan="1">  Single</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">25 (18%)</td><td rowspan="1" colspan="1">7 (17%)</td><td rowspan="1" colspan="1">4 (22%)</td></tr><tr><td rowspan="1" colspan="1">  Married/partnered</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">62 (45%)</td><td rowspan="1" colspan="1">20 (49%)</td><td rowspan="1" colspan="1">9 (50%)</td></tr><tr><td rowspan="1" colspan="1">  Divorced</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">29 (21%)</td><td rowspan="1" colspan="1">6 (15%)</td><td rowspan="1" colspan="1">1 (6%)</td></tr><tr><td rowspan="1" colspan="1">  Widowed</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">23 (17%)</td><td rowspan="1" colspan="1">8 (20%)</td><td rowspan="1" colspan="1">4 (22%)</td></tr><tr><td rowspan="1" colspan="1">Veterans, no. (%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">68 (49%)</td><td rowspan="1" colspan="1">22 (54%)</td><td rowspan="1" colspan="1">9 (50%)</td></tr><tr><td rowspan="1" colspan="1">MCI diagnosis, no. (%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">51 (37%)</td><td rowspan="1" colspan="1">16 (39%)</td><td rowspan="1" colspan="1">5 (28%)</td></tr><tr><td rowspan="1" colspan="1">TBI history<sup>2</sup>, no. (%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">51 (37%)</td><td rowspan="1" colspan="1">16 (39%)</td><td rowspan="1" colspan="1">3 (17%)</td></tr><tr><td rowspan="1" colspan="1">Baseline MoCA, mean (SD)<sup>2</sup></td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">24.0 (1.9)<sup>3</sup></td><td rowspan="1" colspan="1">24.2 (2.0)<sup>4</sup></td></tr></tbody></table><table-wrap-foot><p>SD, standard deviation; MCI, mild cognitive impairment; SMD, subjective memory decline; TBI, traumatic brain injury; MoCA, Montreal Cognitive Assessment <sup>1</sup>181 individuals did not complete the telephone eligibility screening either because they were not interested in or were ineligible for the study. Thus, there is no demographic information about these individuals other than their sex. <sup>2</sup>determined by Ohio State University Traumatic Brain Injury (OSU-TBI) Identification Method. <sup>3</sup>data unavailable for 1 participant with SMD; the scores of the other 5 SMD participants were only recorded as being in the inclusion range (≤26 and &gt; 18). <sup>4</sup>data unavailable for 1 participant; the score for the other participant was recorded only as being in the inclusion range.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sociodemographic Characteristics of Study Completers</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><td/><td>Screened for eligibility1</td><td>Completed Screening</td><td>Enrolled in Study</td><td>Completed Study</td></tr></thead><tbody><tr><td>N</td><td>320</td><td>139</td><td>41</td><td>18</td></tr><tr><td>Sex, no. (%)</td></tr><tr><td>  Male</td><td>232 (73%)</td><td>85 (61%)</td><td>26 (63%)</td><td>11 (61%)</td></tr><tr><td>  Female</td><td>88 (28%)</td><td>54 (39%)</td><td>15 (37%)</td><td>7 (39%)</td></tr><tr><td>MCI diagnosis, no. (%)</td><td>–</td><td>40 (29%)</td><td>10 (24%)</td><td>5 (28%)</td></tr><tr><td>SMD, no. (%)</td><td>–</td><td>87 (63%)</td><td>31 (76%)</td><td>13 (72%)</td></tr><tr><td>Age, mean (SD)</td><td>–</td><td>72.0 (11.0)</td><td>73.1 (9.8)</td><td>75.6 (9.1)</td></tr><tr><td>Education, mean (SD), y</td><td>–</td><td>15.7 (2.8)</td><td>15.5 (2.1)</td><td>14.8 (2.5)</td></tr><tr><td>Race, no. (%)</td></tr><tr><td>  Caucasian</td><td>–</td><td>99 (71%)</td><td>31 (76%)</td><td>16 (89%)</td></tr><tr><td>  Asian/Pacific Islander</td><td>–</td><td>10 (7%)</td><td>4 (10%)</td><td>2 (11%)</td></tr><tr><td>  Hispanic or Latino</td><td>–</td><td>14 (10%)</td><td>1 (2%)</td><td>1 (6%)</td></tr><tr><td>  African American</td><td>–</td><td>18 (13%)</td><td>5 (12%)</td><td>0 (0%)</td></tr><tr><td>  Other</td><td>–</td><td>16 (12%)</td><td>4 (10%)</td><td>2 (11%)</td></tr><tr><td>Marital status, no. (%)</td></tr><tr><td>  Single</td><td>–</td><td>25 (18%)</td><td>7 (17%)</td><td>4 (22%)</td></tr><tr><td>  Married/partnered</td><td>–</td><td>62 (45%)</td><td>20 (49%)</td><td>9 (50%)</td></tr><tr><td>  Divorced</td><td>–</td><td>29 (21%)</td><td>6 (15%)</td><td>1 (6%)</td></tr><tr><td>  Widowed</td><td>–</td><td>23 (17%)</td><td>8 (20%)</td><td>4 (22%)</td></tr><tr><td>Veterans, no. (%)</td><td>–</td><td>68 (49%)</td><td>22 (54%)</td><td>9 (50%)</td></tr><tr><td>MCI diagnosis, no. (%)</td><td>–</td><td>51 (37%)</td><td>16 (39%)</td><td>5 (28%)</td></tr><tr><td>TBI history2, no. (%)</td><td>–</td><td>51 (37%)</td><td>16 (39%)</td><td>3 (17%)</td></tr><tr><td>Baseline MoCA, mean (SD)2</td><td>–</td><td>–</td><td>24.0 (1.9)3</td><td>24.2 (2.0)4</td></tr></tbody></table></div>SD, standard deviation; MCI, mild cognitive impairment; SMD, subjective memory decline; TBI, traumatic brain injury; MoCA, Montreal Cognitive Assessment 1181 individuals did not complete the telephone eligibility screening either because they were not interested in or were ineligible for the study. Thus, there is no demographic information about these individuals other than their sex. 2determined by Ohio State University Traumatic Brain Injury (OSU-TBI) Identification Method. 3data unavailable for 1 participant with SMD; the scores of the other 5 SMD participants were only recorded as being in the inclusion range (≤26 and &gt; 18). 4data unavailable for 1 participant; the score for the other participant was recorded only as being in the inclusion range.</transformed-table></extracted-table><extracted-table><table-id>jad-82-jad210159-t002</table-id><table-label>Table 2</table-label><table-caption>Strength of functional connectivity within DMN nodes pre- and post-PLIÉ</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="jad-82-jad210159-t002" orientation="portrait" position="float"><label>Table 2</label><caption><p>Strength of functional connectivity within DMN nodes pre- and post-PLIÉ</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1">Connection</td><td colspan="2" align="center" rowspan="1">Pre-PLIÉ</td><td colspan="2" align="center" rowspan="1">Post-PLIÉ</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><italic>t</italic>(16)</td><td rowspan="1" colspan="1"><italic>p</italic><sub>FDR</sub></td><td rowspan="1" colspan="1"><italic>t</italic>(16)</td><td rowspan="1" colspan="1"><italic>p</italic><sub>FDR</sub></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">1. RHP &amp;  LHP</td><td rowspan="1" colspan="1">8.54</td><td rowspan="1" colspan="1">0.000001</td><td rowspan="1" colspan="1">8.22</td><td rowspan="1" colspan="1">0.000002</td></tr><tr><td rowspan="1" colspan="1">2. RLP &amp;  LLP</td><td rowspan="1" colspan="1">7.44</td><td rowspan="1" colspan="1">0.000007</td><td rowspan="1" colspan="1">10.46</td><td rowspan="1" colspan="1">&lt; 0.000001</td></tr><tr><td rowspan="1" colspan="1">3. PCC &amp;  RLP</td><td rowspan="1" colspan="1">6.03</td><td rowspan="1" colspan="1">0.000004</td><td rowspan="1" colspan="1">7.18</td><td rowspan="1" colspan="1">0.000001</td></tr><tr><td rowspan="1" colspan="1">4. PCC &amp;  LLP</td><td rowspan="1" colspan="1">6.50</td><td rowspan="1" colspan="1">0.000002</td><td rowspan="1" colspan="1">8.15</td><td rowspan="1" colspan="1">0.000001</td></tr><tr><td rowspan="1" colspan="1">5. PCC &amp;  LHP</td><td rowspan="1" colspan="1">3.56</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1">6. mPFC &amp;  PCC</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">2.26</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">7. mMPFC &amp;  LLP</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">3.21</td><td rowspan="1" colspan="1">0.005</td></tr><tr><td rowspan="1" colspan="1">8. mPFC &amp;  RHP</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">3.09</td><td rowspan="1" colspan="1">0.02</td></tr></tbody></table><table-wrap-foot><p>R, right; L, left; H, hippocampus; LP, lateral parietal; PCC, posterior cingulate cortex; mPFC, medial prefrontal cortex.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Strength of functional connectivity within DMN nodes pre- and post-PLIÉ</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><td>Connection</td><td colspan="2" align="center">Pre-PLIÉ</td><td colspan="2" align="center">Post-PLIÉ</td></tr><tr><td/><td>t(16)</td><td>pFDR</td><td>t(16)</td><td>pFDR</td></tr></thead><tbody><tr><td>1. RHP &amp;  LHP</td><td>8.54</td><td>0.000001</td><td>8.22</td><td>0.000002</td></tr><tr><td>2. RLP &amp;  LLP</td><td>7.44</td><td>0.000007</td><td>10.46</td><td>&lt; 0.000001</td></tr><tr><td>3. PCC &amp;  RLP</td><td>6.03</td><td>0.000004</td><td>7.18</td><td>0.000001</td></tr><tr><td>4. PCC &amp;  LLP</td><td>6.50</td><td>0.000002</td><td>8.15</td><td>0.000001</td></tr><tr><td>5. PCC &amp;  LHP</td><td>3.56</td><td>0.004</td><td>–</td><td>–</td></tr><tr><td>6. mPFC &amp;  PCC</td><td>–</td><td>–</td><td>2.26</td><td>0.06</td></tr><tr><td>7. mMPFC &amp;  LLP</td><td>–</td><td>–</td><td>3.21</td><td>0.005</td></tr><tr><td>8. mPFC &amp;  RHP</td><td>–</td><td>–</td><td>3.09</td><td>0.02</td></tr></tbody></table></div>R, right; L, left; H, hippocampus; LP, lateral parietal; PCC, posterior cingulate cortex; mPFC, medial prefrontal cortex.</transformed-table></extracted-table><extracted-table><table-id>jad-82-jad210159-t003</table-id><table-label>Table 3</table-label><table-caption>Correlation (Spearman’s ρ) between strength of DMN functional connectivity (β) and ADAS-cog total and memory subcomponent scores</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="jad-82-jad210159-t003" orientation="portrait" position="float"><label>Table 3</label><caption><p>Correlation (Spearman’s <italic>ρ</italic>) between strength of DMN functional connectivity (β) and ADAS-cog total and memory subcomponent scores</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1"/><td colspan="2" align="center" rowspan="1">ADAS-cog</td><td colspan="2" align="center" rowspan="1">Immediate Recall</td><td colspan="2" align="center" rowspan="1">Delayed Recall</td></tr><tr><td rowspan="1" colspan="1">Connection</td><td rowspan="1" colspan="1">Pre-PLIÉ</td><td rowspan="1" colspan="1">Post-PLIÉ</td><td rowspan="1" colspan="1">Pre-PLIÉ</td><td rowspan="1" colspan="1">Post-PLIÉ</td><td rowspan="1" colspan="1">Pre-PLIÉ</td><td rowspan="1" colspan="1">Post-PLIÉ</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">1. RHP &amp;LHP</td><td rowspan="1" colspan="1">–0.03</td><td rowspan="1" colspan="1">–0.19</td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1">–0.04</td><td rowspan="1" colspan="1">–0.09</td><td rowspan="1" colspan="1">–0.22</td></tr><tr><td rowspan="1" colspan="1">2. RLP &amp;LLP</td><td rowspan="1" colspan="1">–0.02</td><td rowspan="1" colspan="1">–0.24</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">–0.04</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">–0.11</td></tr><tr><td rowspan="1" colspan="1">3. PCC &amp;RLP</td><td rowspan="1" colspan="1">0.42</td><td rowspan="1" colspan="1">0.24</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.36</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">0.29</td></tr><tr><td rowspan="1" colspan="1">4. PCC &amp;LLP</td><td rowspan="1" colspan="1">0.22</td><td rowspan="1" colspan="1">–0.36</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">–0.18</td><td rowspan="1" colspan="1">0.34</td><td rowspan="1" colspan="1">–0.30</td></tr><tr><td rowspan="1" colspan="1">5. PCC &amp;LHP</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">–0.13</td><td rowspan="1" colspan="1">–0.02</td><td rowspan="1" colspan="1">–0.13</td><td rowspan="1" colspan="1">–0.03</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="1" colspan="1">6. mPFC &amp;PCC</td><td rowspan="1" colspan="1">–0.21</td><td rowspan="1" colspan="1">–0.25</td><td rowspan="1" colspan="1">–0.06</td><td rowspan="1" colspan="1">–0.22</td><td rowspan="1" colspan="1">–0.09</td><td rowspan="1" colspan="1">–0.26</td></tr><tr><td rowspan="1" colspan="1">7. mPFC &amp;LLP</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">–0.74<sup>a</sup></td><td rowspan="1" colspan="1">–0.14</td><td rowspan="1" colspan="1">–0.72<sup>a</sup></td><td rowspan="1" colspan="1">–0.02</td><td rowspan="1" colspan="1">–0.69<sup>b</sup></td></tr><tr><td rowspan="1" colspan="1">8. mPFC &amp;RHP</td><td rowspan="1" colspan="1">–0.29</td><td rowspan="1" colspan="1">–0.83<sup>c</sup></td><td rowspan="1" colspan="1">–0.30</td><td rowspan="1" colspan="1">–0.84<sup>d</sup></td><td rowspan="1" colspan="1">–0.16</td><td rowspan="1" colspan="1">–0.80<sup>e</sup></td></tr></tbody></table><table-wrap-foot><p>R, right; L, left; H, hippocampus; LP, lateral parietal; PCC, posterior cingulate cortex; mPFC, medial prefrontal cortex <sup>a</sup><italic>p</italic> = 0.001, <sup>b</sup><italic>p</italic> = 0.002, <sup>c</sup><italic>p</italic> = 0.00004, <sup>d</sup><italic>p</italic> = 0.00003, <sup>e</sup><italic>p</italic> = 0.0001.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Correlation (Spearman’s ρ) between strength of DMN functional connectivity (β) and ADAS-cog total and memory subcomponent scores</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><td/><td colspan="2" align="center">ADAS-cog</td><td colspan="2" align="center">Immediate Recall</td><td colspan="2" align="center">Delayed Recall</td></tr><tr><td>Connection</td><td>Pre-PLIÉ</td><td>Post-PLIÉ</td><td>Pre-PLIÉ</td><td>Post-PLIÉ</td><td>Pre-PLIÉ</td><td>Post-PLIÉ</td></tr></thead><tbody><tr><td>1. RHP &amp;LHP</td><td>–0.03</td><td>–0.19</td><td>0.20</td><td>–0.04</td><td>–0.09</td><td>–0.22</td></tr><tr><td>2. RLP &amp;LLP</td><td>–0.02</td><td>–0.24</td><td>0.13</td><td>–0.04</td><td>0.06</td><td>–0.11</td></tr><tr><td>3. PCC &amp;RLP</td><td>0.42</td><td>0.24</td><td>0.44</td><td>0.36</td><td>0.38</td><td>0.29</td></tr><tr><td>4. PCC &amp;LLP</td><td>0.22</td><td>–0.36</td><td>0.17</td><td>–0.18</td><td>0.34</td><td>–0.30</td></tr><tr><td>5. PCC &amp;LHP</td><td>0.01</td><td>–0.13</td><td>–0.02</td><td>–0.13</td><td>–0.03</td><td>0.01</td></tr><tr><td>6. mPFC &amp;PCC</td><td>–0.21</td><td>–0.25</td><td>–0.06</td><td>–0.22</td><td>–0.09</td><td>–0.26</td></tr><tr><td>7. mPFC &amp;LLP</td><td>0.08</td><td>–0.74a</td><td>–0.14</td><td>–0.72a</td><td>–0.02</td><td>–0.69b</td></tr><tr><td>8. mPFC &amp;RHP</td><td>–0.29</td><td>–0.83c</td><td>–0.30</td><td>–0.84d</td><td>–0.16</td><td>–0.80e</td></tr></tbody></table></div>R, right; L, left; H, hippocampus; LP, lateral parietal; PCC, posterior cingulate cortex; mPFC, medial prefrontal cortex ap = 0.001, bp = 0.002, cp = 0.00004, dp = 0.00003, ep = 0.0001.</transformed-table></extracted-table><extracted-table><table-id>jad-82-jad210159-t004</table-id><table-label>Table 4</table-label><table-caption>Pre- and Post-PLIÉ effects on secondary behavioral and imaging outcome measures</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="jad-82-jad210159-t004" orientation="portrait" position="float"><label>Table 4</label><caption><p>Pre- and Post-PLIÉ effects on secondary behavioral and imaging outcome measures</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Pre-PLIÉ (SD)</td><td rowspan="1" colspan="1">Post-PLIÉ (SD)</td><td rowspan="1" colspan="1">Effect size (95%CI)</td><td rowspan="1" colspan="1"><italic>p</italic></td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>Behavioral Measures</italic></td></tr><tr><td rowspan="1" colspan="1">  MAIA-2 Self-regulation</td><td rowspan="1" colspan="1">3.3 (1.4)</td><td rowspan="1" colspan="1">4.1 (0.7)</td><td rowspan="1" colspan="1">–0.72 (–1.40, –1.07)</td><td rowspan="1" colspan="1">0.005<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  MAIA-2 Attention Regulation</td><td rowspan="1" colspan="1">3.1 (1.3)</td><td rowspan="1" colspan="1">3.6 (0.8)</td><td rowspan="1" colspan="1">–0.46 (–0.20, 1.25)</td><td rowspan="1" colspan="1">0.07<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  PROMIS Social Isolation<sup>a,b</sup></td><td rowspan="1" colspan="1">9.6 (2.7)</td><td rowspan="1" colspan="1">7.9 (2.1)</td><td rowspan="1" colspan="1">0.70 (–0.12, 1.80)</td><td rowspan="1" colspan="1">0.02<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  NeuroQOL- Well Being<sup>a</sup></td><td rowspan="1" colspan="1">34.7 (4.6)</td><td rowspan="1" colspan="1">37.2 (4.3)</td><td rowspan="1" colspan="1">–0.56 (–1.38, –0.68)</td><td rowspan="1" colspan="1">0.03<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  NeuroQOL- Lower Extremity Function<sup>a</sup></td><td rowspan="1" colspan="1">38.0 (2.1)</td><td rowspan="1" colspan="1">37.2 (3.2)</td><td rowspan="1" colspan="1">0.30 (–0.51, 0.99)</td><td rowspan="1" colspan="1">0.13<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  SPPB</td><td rowspan="1" colspan="1">8.6 (2.1)</td><td rowspan="1" colspan="1">9.4 (2.3)</td><td rowspan="1" colspan="1">–0.36 (–1.02, –0.38)</td><td rowspan="1" colspan="1">0.06<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  QOL-AD</td><td rowspan="1" colspan="1">35.6 (6.0)</td><td rowspan="1" colspan="1">37.2 (6.2)</td><td rowspan="1" colspan="1">–0.26 (–0.92, –0.18)</td><td rowspan="1" colspan="1">0.08<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1">  GDS<sup>b</sup></td><td rowspan="1" colspan="1">3.8 (2.5)</td><td rowspan="1" colspan="1">3.1 (2.8)</td><td rowspan="1" colspan="1">0.26 (–0.39, 0.85)</td><td rowspan="1" colspan="1">0.11<sup>c</sup></td></tr><tr><td rowspan="1" colspan="1"><italic>Total and Hippocampal subfield volume</italic> (mm<sup>3</sup>)</td></tr><tr><td rowspan="1" colspan="1">  Total Hippocampus</td><td rowspan="1" colspan="1">6321.71 (1197.06)</td><td rowspan="1" colspan="1">6369.19 (1234.85)</td><td rowspan="1" colspan="1">–0.04 (–0.69, 0.26)</td><td rowspan="1" colspan="1">0.07<sup>d</sup></td></tr><tr><td rowspan="1" colspan="1">  CA1</td><td rowspan="1" colspan="1">1177.54 (251.78)</td><td rowspan="1" colspan="1">1187.58 (255.87)</td><td rowspan="1" colspan="1">–0.04 (–0.69, 0.26)</td><td rowspan="1" colspan="1">0.14</td></tr><tr><td rowspan="1" colspan="1">  CA3</td><td rowspan="1" colspan="1">379.06 (87.45)</td><td rowspan="1" colspan="1">382.36 (91.43)</td><td rowspan="1" colspan="1">–0.04 (–0.69, 0.26)</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">  CA4</td><td rowspan="1" colspan="1">492.44 (116.66)</td><td rowspan="1" colspan="1">497.41 (121.69)</td><td rowspan="1" colspan="1">–0.04 (–0.70, 0.25)</td><td rowspan="1" colspan="1">0.08<sup>d</sup></td></tr><tr><td rowspan="1" colspan="1">  Dentate Gyrus</td><td rowspan="1" colspan="1">548.36 (125.28)</td><td rowspan="1" colspan="1">554.73 (130.50)</td><td rowspan="1" colspan="1">–0.05 (–0.70, 0.24)</td><td rowspan="1" colspan="1">0.05<sup>d</sup></td></tr><tr><td rowspan="1" colspan="1">  Presubiculum</td><td rowspan="1" colspan="1">547.82 (106.35)</td><td rowspan="1" colspan="1">552.83 (111.61)</td><td rowspan="1" colspan="1">–0.05 (–0.70, 0.24)</td><td rowspan="1" colspan="1">0.32</td></tr><tr><td rowspan="1" colspan="1">  Subsiculum</td><td rowspan="1" colspan="1">768.15 (161.03)</td><td rowspan="1" colspan="1">774.69 (159.14)</td><td rowspan="1" colspan="1">–0.04 (–0.69, 0.25)</td><td rowspan="1" colspan="1">0.23</td></tr></tbody></table><table-wrap-foot><p>MAIA-2, Multidimenstional Assessment of Interoceptive Awareness 2, SPPB, Short Physical Performance Battery; QOL-AD, Quality of Life Alzheimer’s Disease; GDS, Geriatric Depression Scale <sup>a</sup>Data available for 12 participants because measure was not implemented in first PLIÉ group <sup>b</sup>lower score = better outcome <sup>c</sup><italic>p</italic>-value calculated using Wilcoxon signed-rank test <sup>d</sup><italic>p</italic>-value calculated from paired <italic>t</italic>-test.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Pre- and Post-PLIÉ effects on secondary behavioral and imaging outcome measures</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><td/><td>Pre-PLIÉ (SD)</td><td>Post-PLIÉ (SD)</td><td>Effect size (95%CI)</td><td>p</td></tr></thead><tbody><tr><td>Behavioral Measures</td></tr><tr><td>  MAIA-2 Self-regulation</td><td>3.3 (1.4)</td><td>4.1 (0.7)</td><td>–0.72 (–1.40, –1.07)</td><td>0.005c</td></tr><tr><td>  MAIA-2 Attention Regulation</td><td>3.1 (1.3)</td><td>3.6 (0.8)</td><td>–0.46 (–0.20, 1.25)</td><td>0.07c</td></tr><tr><td>  PROMIS Social Isolationa,b</td><td>9.6 (2.7)</td><td>7.9 (2.1)</td><td>0.70 (–0.12, 1.80)</td><td>0.02c</td></tr><tr><td>  NeuroQOL- Well Beinga</td><td>34.7 (4.6)</td><td>37.2 (4.3)</td><td>–0.56 (–1.38, –0.68)</td><td>0.03c</td></tr><tr><td>  NeuroQOL- Lower Extremity Functiona</td><td>38.0 (2.1)</td><td>37.2 (3.2)</td><td>0.30 (–0.51, 0.99)</td><td>0.13c</td></tr><tr><td>  SPPB</td><td>8.6 (2.1)</td><td>9.4 (2.3)</td><td>–0.36 (–1.02, –0.38)</td><td>0.06c</td></tr><tr><td>  QOL-AD</td><td>35.6 (6.0)</td><td>37.2 (6.2)</td><td>–0.26 (–0.92, –0.18)</td><td>0.08c</td></tr><tr><td>  GDSb</td><td>3.8 (2.5)</td><td>3.1 (2.8)</td><td>0.26 (–0.39, 0.85)</td><td>0.11c</td></tr><tr><td>Total and Hippocampal subfield volume (mm3)</td></tr><tr><td>  Total Hippocampus</td><td>6321.71 (1197.06)</td><td>6369.19 (1234.85)</td><td>–0.04 (–0.69, 0.26)</td><td>0.07d</td></tr><tr><td>  CA1</td><td>1177.54 (251.78)</td><td>1187.58 (255.87)</td><td>–0.04 (–0.69, 0.26)</td><td>0.14</td></tr><tr><td>  CA3</td><td>379.06 (87.45)</td><td>382.36 (91.43)</td><td>–0.04 (–0.69, 0.26)</td><td>0.25</td></tr><tr><td>  CA4</td><td>492.44 (116.66)</td><td>497.41 (121.69)</td><td>–0.04 (–0.70, 0.25)</td><td>0.08d</td></tr><tr><td>  Dentate Gyrus</td><td>548.36 (125.28)</td><td>554.73 (130.50)</td><td>–0.05 (–0.70, 0.24)</td><td>0.05d</td></tr><tr><td>  Presubiculum</td><td>547.82 (106.35)</td><td>552.83 (111.61)</td><td>–0.05 (–0.70, 0.24)</td><td>0.32</td></tr><tr><td>  Subsiculum</td><td>768.15 (161.03)</td><td>774.69 (159.14)</td><td>–0.04 (–0.69, 0.25)</td><td>0.23</td></tr></tbody></table></div>MAIA-2, Multidimenstional Assessment of Interoceptive Awareness 2, SPPB, Short Physical Performance Battery; QOL-AD, Quality of Life Alzheimer’s Disease; GDS, Geriatric Depression Scale aData available for 12 participants because measure was not implemented in first PLIÉ group blower score = better outcome cp-value calculated using Wilcoxon signed-rank test dp-value calculated from paired t-test.</transformed-table></extracted-table></extracted-tables-set>